Related Experiment Videos
Left ventricular function following thrombolytic therapy for myocardial infarction
1Cardiology Department, Green Lane Hospital, Auckland, New Zealand.
Clinical and Experimental Pharmacology & Physiology
|March 1, 1995
Summary
Measuring left ventricular function is crucial for assessing thrombolytic therapy effectiveness after myocardial infarction. Improved left ventricular function significantly correlates with reduced mortality, guiding treatment strategies.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Thrombolytic therapy has significantly reduced mortality from cardiac failure post-myocardial infarction.
- Left ventricular function remains a critical prognostic indicator following acute myocardial infarction recovery.
Purpose of the Study:
- To evaluate the utility of left ventricular function measurements in assessing thrombolytic agent efficacy.
- To determine the prognostic value of left ventricular function in the context of thrombolytic therapy.
Main Methods:
- Systematic review of published studies.
- Analysis of clinical trials assessing left ventricular function and survival outcomes.
- Examination of data from the Global Utility of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) Trial.
Main Results:
- Three trials demonstrated improved left ventricular function and survival with thrombolytic therapy compared to placebo.
- Left ventricular function, assessed via ejection fraction, end-systolic volume, or infarct zone contractility at 90 minutes, strongly correlated with 30-day mortality (P < 0.01).
- The GUSTO Trial findings support the correlation between left ventricular function and mortality reduction.
Conclusions:
- Left ventricular function is a key metric for evaluating the effectiveness of thrombolytic agents and adjuvant regimens.
- Accurate assessment of left ventricular function aids in predicting patient outcomes after myocardial infarction treated with thrombolytics.